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Summary.-The specificity of action of mature blood cell extracts on their own
progenitor cells was investigated by measuring their effects on the structuredness
of the cytoplasmic matrix (SCM) using the technique of fluorescence polarization.
Changes in SCM induced by the various extracts are probably closely related to the
proliferation state of the cells.
Saline extracts of lymphocytes, granulocytes and erythrocytes (LNE, GCE and
RCE respectively) have been partially purified byultrafiltration into selected molecu-
lar weight ranges and each tested against proliferative populations of lymphoid,
granulocytic and erythroid cells. In all cases, complete specificity of effect on SCM
was found, LNEs affecting only lymphoid cell populations, GCEs affecting only the
granulocytic cell populations and RCEs affecting only erythroid cells. In each case,
with the possible exception of the RCEs, the active fractions reside in the molecular
weight ranges reported in the literature
inhibitory properties.
A NUMBER ofinvestigators have claim-
ed that extracts from the mature elements
ofthe blood system (erythrocytes, granulo-
cytes and lymphocytes) have specific
inhibitory effects on the proliferation ofthe
progenitors of those cells (Rytomaa and
Kiviniemi, 1968; Moorhead et al., 1969;
Houck, Irausquin and Leikin, 1971;
Kivilaasko and Rytomaa, 1971). These
extracts have frequently been called
" chalones " and a number of properties
which a compound must demonstrate
before qualifying for that title have been
defined (NCI Monograph 38, 1973). One
of these properties, that of specificity of
action for cells oftheir own kind, has so far
proved defiant to unequivocal demonstra-
tion. Most observations have depended
on the uptake oftritium labelledthymidine
into cells synthesizing DNA in culture
systems; systems which can very rapidly
deteriorate unless exact culture conditions
are maintained throughout. Comparisons
have been made of the inhibition of thy-
midine uptake by one cell type with that
for cell extracts possessing proliferation
of other cell types in the culture. How-
ever, it is well recognized that while
granulocytic cells can be maintained in a
reasonablyhealthy conditionundervarious
culture conditions, erythroid cells are
difficult to culture.
Consequently, comparative measure-
ments of these two types of cells in the
same culture system are rather unreliable
and can give only an indication of the
direction of an effect.
The use ofthymidine as a markerleads,
in itself, to problems. It has been
demonstrated that tissue extracts often
contain thymidine. This serves to dilute
the specific activity of the labelled
thymidine, which then can result in
lowered incorporation, i.e. apparent inhibi-
tion of DNA synthesis. Lenfant, Kren-
Proschek and Verly (1973) demonstrated
this effect, for example, in their work on
the liver " chalone ".
Another difficulty arising from reports
of work undertaken to demonstrate cellu-
lar specificity is that comparative tests areINHIBITORS OF HAEMOPOIETIC CELL PROLIFERATION?
oftein made using similar extracts from
widely differing tissues, e.g. muscle, liver,
brain, kidney, fibroblasts, lung, skin,
Harding-Passey melanoma (Bullough and
Laurence, 1970; Houck and Irausquin,
1973; Rytdmaa, 1973) and testing them on
haemopoietic tissues. Alternatively, the
haemopoietic extracts have been tested on
other types of tissue, e.g. fibroblasts
(Houck, Weil and Sharma, 1972). In
many cases, the end points in comparative
tests may be different, e.g. cellularity,
tritiated thymidine incorporation or
colony production. Erythroid, granulo-
cytic and, in the mouse at least, lymphoid
cells develop from a common haemo-
poietic stem cell and are very closely
related. It is therefore, necessary, in
order to demonstrate absolute specificity
of action, to test all the extracts on the
progenitor cells of each haemopoietic cell
line.
In this paper a new method of ap-
proaching the problem of specificity of
growth control will be described, in which
it has proved possible to compare the
effects of various blood cell extracts on
each type of haemopoietic cell line, under
virtually identical conditions and with the
same end point. To make these com-
parisons, the structuredness of the cyto-
plasmic matrix (SCM) was measured with
the technique of fluorescence polarization
elaborated by Cercek and Cercek (1972a,
] 973c). The technique is based on the
excitation of fluorescein molecules, pro-
duced by enzymatic hydrolysis ofthe non-
fluorescing fluoresceindiacetate (FDA) in
the cytoplasm with polarized light and,
measurement of the polarization of the
emitted fluorescence. Rotational relaxa-
tion of the fluorescein molecule between
absorption andemission oflight depolarizes
the fluorescence. Rotation of the fluor-
escein molecules depends on the physical
state of organization of the cytoplasmic
matrix at the molecular level (Cercek and
Cercek, 1973a). This organization is the
result of physical interactions between
macromolecules such as proteins, water
molecules and solutes (Ling, 1972). Per-
turbations of these interactionis result in a
change in SCM (Cercek and Cercek, 1972a,
b, 1973a, b; Cercek, Cercek and Ockey,
1973c; Cercek, Cercek and Garrett, 1973d).
The degree offluorescence polarization (P)
increases with increasing SCM and vice
versa.
MATERIALS AND METHOD)S
Preparation of test extracts
(a) Lymph node extracts (LNE). 100 g fresh bovine mesenteric lymph nodes were
stripped of fat from their capsules and
minced in a Waring blender for 30 seconds in
physiological saline. The freed cells and
debris from the nodes were spun down andthe
supernatant discarded. The pellet was re-
suspended in 11 saline and incubated over-
night at 4°C. After incubation, the cellular
material was spundown(20 minat2500 g) and
the supernatant retained as the crude extract.
This wNas dialized against distilled water (2
changes at a volume ratio of approximately 20: 1) for 48 hours at 4°C to precipitate euglobulins, which wN-ere then removed by centrifugation. The supernatant was filtered
throughWhatman No. 2 filterpaper to remove
fat globules and then through a series of
millipore filters of reducing pore size, finish-
ing with a 0-22 ,um filter for sterilization.
Finally, it was fractionated by ultrafiltration
through Amicon Diaflo filter membranes to
obtain a partially purified extract in the
molecular weightrange30,000-50,000 daltons.
According to published data, the active lymphoid inhibitor lies in this range (Lasalvia, Garcia-Giralt and Macieiro-Coelho, 1970; Houck et al., 1971).
For comparison with the erythrocyte and
granulocyte extracts (see below), further
Diaflo fractions were obtained in the molecu- lar weight range of 500-1000 daltons and
1000-10,000 daltons. In these cases, how-
ever, the dialysis step was omitted.
(b) Granulocyte extracts (GCE).-Thirty male Wister rats, 250-300 g body weight were
injected i.p. with 2 doses of 15 ml of 3-500 polyvinylpyrrolidone, 17 hours apart. 2-4 hours after the second injection, peritoneal fluid was removed from the rats and 250 i.u.
of heparin added to the fluid to prevent co- agulation. The cells were washed in saline
and then resuspended in fresh saline at a con-
centration of 5 x 106 cells/ml. Each rat
yielded approximately 2 x 108 cells, ofwhich
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about 85% were mature granulocytes and
15% were macrophages. The cell suspension
was then incubated for 2 hours at 37°C and
the cells removed by centrifugation; the
supernatant was passed through millipore
filters and finally fractionated on Diaflo
filters. The molecular weight range fractions
retained were 500-1000 daltons, 1000-10,000
daltons and, for comparison with the LNEs,
30,000-50,000 daltons. The 2 smaller frac-
tions include the molecular weight reported
both for the active GCE and for the active
erythroid cell inhibitor (Rytomaa and Kivi-
niemi, 1968; Paukovits, 1971; Kivilaasko and
Rytomaa, 1971).
(c) Erythrocyte extracts (RCE). Ten male
Wistar rats, 250-300 g body weight were bled
from the axillary vessels under ether anaes-
thesia; 100i.u. ofheparinwasaddedtoprevent
coagulation. Red blood cells were sedi-
mented by centrifugation (10 min at 500 g)
and the plasma and buffy coat removed.
The erythrocytes were washed twice in saline
andfinally resuspended in saline at about50%0
haematocrit. Extracts were then prepared
and fractionated as from the granulocytes.
Preparation of test cells
Human peripheral lymphocytes were
prepared from blood collected in Searle-
LH/10 lithium heparin containing vials.
Macrophages were removed by the carbonyl
iron technique (Kuper, Bignall and Luckcock,
1961). Lymphocytes in a pure state
(> 90%) were obtained by the Ficoll-Triosil
gradient separation (Harris and Ukaejiofo,
1969). The lymphocytes were washed twice
with saline and once in TC Medium 199
(Wellcome Ltd) and resuspended in TC
Medium 199 at the concentration of 5 x 106
cells/ml. For stimulation of lymphocytes a
5-times diluted Reagent Grade PHA (Well-
come Ltd) was used; 01 ml of the diluted
PHA were added to 1 ml of cell suspensions.
This stimulated lymphocyte culture served as
the baseline control for the subsequent
inhibitor testing.
Granulocytic cells proliferating in a long
term (2-10 week) culture system developed by
Dexter et al. (1974) were harvested, washed
and resuspended in serum-free TC 199
medium. In such a culture at least 90%0 of
the cells are granulocytic and in all stages of
development.
Normoblasts from mouse foetal liver were
used for the third cell population. Livers
wN,ere removed from 16-day old embryos,
broken into a single cell suspension in TC 199
medium by aspiration through progressively
smaller needles, washed and resuspended in
serum-free TC 199 medium; 90 to 95%0 of the
nucleated cells in this suspension are develop-
ing erythroid cells.
Measurernent ofSCM
SCM was measured by the degree of
fluorescence polarization of fluorescein mole-
cules in the cytoplasmic matrix. For this pur-
pose the cells were suspended at concen-
trations of 105 cells/ml in 2-5 jumol/l fluores-
ceindiacetate (FDA) solution in phosphate
buffered saline. The suspension wN-as rapidly
transferredinto a 1 cmcuvette and putintothe
thermostatically controlled cuvette holder of
the Perkin-Elmer MPF-2A fluorescence spec-
trophotometer fitted with the polarization
accessory. Measurements wN-ere made at
27°C. The excitation monochromator was
set at 473 nm and the emission mono-
chromator at 510 nm. Details of the experi-
mental procedures and calculations of fluor-
escence polarization values, P, wkere the same
as those described in experiments when
changes in SCM wNere measured in Chinese
hamster ovary cells (Cercek et al., 1973c).
We estimate the values of P in these experi-
ments to be accurate to within 500.
For the purpose of measurements all test
cell suspensions were reconstituted to a con-
centration of5 x 106 cells/ml. In the case of
lymphocytes an initial measurement of the
SCM was made before stimulating with PHA.
A further measurement was made 15-30 min
after PHA and this served as the control
value for subsequent tests. The control
SCM value for the other 2 cell types wNas
measured on the initial cell suspension.
Each test extract wNas dissolved in TC 199
medium at a concentration of 100 tg/ml and
added to an aliquot of the test cell suspension
to a final concentration of 33 ,ug/ml. All
three extracts and fractions (500-1000, 1000-
10,000 and 30,000-50,000 daltons) wN-ere tested
on all 3 cell preparations. In all cases
replicate measurements were made at 30 and
40 min after treating with the test extract.
At the end of each series of tests repeat
measurements of the controls were made to
check that the original condition of the cells
had not changed.
170INHIBITORS OF HAEMOPOIETIC CELL PROLIFERATION?
RESULTS
Three major series ofexperiments were
carried out. First, lymphocytes prepared
in the manner described were tested with
all 9 fractions. In each case, the SCM of
the cells was measured 30-40 min after
treating the PHA stimulated lymphocytes
with the appropriate fractions of the
extracts. The results are shown in Table
I. Normal lymphocytes of the particular
TABLE I.-SCM of Normal Human
Peripheral Lymphocytes
Polarization P /O
Treatment value P control
Normal lymphocytes (NL) 0 191 135
NL+PHA (30 min) 0-142 100
Extract
Lymph no(le
extract
(LNE)
Granulocyte
extract
(GCE)
Erythrocyte
extract
(RCE)
Molecular
weight range
500-1000
1000-10000
30000-50000
500-1000
1000-10000
30000-50000
500-1000
1000-10000
30000-50000
0 145
0 153
0 205
0 144
0-145
0 142
0 140
0 140
0- 140
102
107
144
101
102
100
99
99
99
The SCMI of cells is measured by the fluorescence
polarization value, P. All measurements were madle
.30-40 min after treatment with cell extract.
donor had a fluorescence polarization
value, P, (SCM) of 0 191 which on stimula-
tion with PHA decreased to 0142 (740% of
normal). Since normal lymphocytes are
non-proliferating, the SCM value of PHA
stimulated lymphocytes was taken as the
100% level for comparison with extract
treated samples. It can be seen from the
Table that the only extract to have an
effect was the 30,000-50,000 dalton extract
from lymph nodes, the P value rising to
0 205, 144% of the stimulated control.
All other extracts were without effect.
With the cultured granulocytopoietic
cells (Table II) the only extract to have a
significant effect on the initial SCM
(P 0.176) was the 500-1000 daltons
fraction from granulocytes. This extract
increased the SCM to a value of P 0 249
(142% of control). The larger GCE
fraction at 1000-10,000 daltons was also
TABLE II. SCM of Granulocytopoietic
Cells
Treatment
Granulocytopoietic cells
Extract
Lymph node
extract
(LNE)
Granulocyte
extract
(GCE)
Erythrocyte
extract
(RCE)
Molecular
weight range
500-1000
1000-10000
30000-50000
500-1000
1000-10000
30000-50000
500-1000
1000-10000
30000-50000
Polarization
value P
0 - 176
01 83
0 171
0-180
0 249
0-199
0 183
0- 171
0 - 171
0 168
P %
control
100
104
98
102
142
113
104
98
98
96
The SCM of cells is measuredt by the fluorescence
polarization value, P. All measurements were made
30-40 min after treatment with cell extract.
somewhat effective, raising the SCAI to
P 0d199 (113% of control). The high
molecular weight fraction of GCE, the
LNE fractions and the RCE fractions were
all without effect.
In the same way for the erythroid cells,
the initial SCM ofP = 0X147 offoetal liver
normoblasts (Table III) was changed only
TABLE III. SCM ofFoetal Liver
Normoblasts
Treatment
16d. Foetal liver cells
Extract
Lymph node
extract
(LNE)
Granulocyte
extract
(GCE)
Erythrocyte
extract
(RCE)
Molecular
weight range
500-1000
1000-10000
30000-50000
500-1000
1000-10000
30000-50000
500-1000
1000-10000
30000-50000
Polarization
value P
0* 147
0* 149
01-155
0* 150
0 142
0 * 153
0* 152
0- 223
0 217
0 215
p 00
control
100
102
105
102
97
104
104
151
148
146
The SCM of cells is measurect by the fluorescence
polarization value, P. All measurements were made
30-40 min after treatment with cell extract.
by the extracts from erythrocytes. How-
ever, in this case, all 3 RCEs were equally
effective, the 500-1000, 1000-10,000 and
30,000-50,000 daltonfractionsrespectively
raising the SCM to values of P 0-223
(151 Qo of control), 0-217 (148% of control)
and 0-215 (146% of control).
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A more limited experiment was also
carried out on proliferating lymphocytes.
Normal peripheral lymphocytes were
stimulated with PHA. After 2 hours the
cells were washed and the culture re-
established without PHA for a further
46 hours. The dose ofPHA was sufficient
to allow the subsequent proliferation ofthe
lymphocytes (Soren, 1973) which at 48
hours were at the first main peak of DNA
synthesis. These cells were washed, re-
suspended in serum-free TC 199 medium
and treated with LNE (30,000-50,000
daltons) and GCE (500-10,000 daltons).
Table IV shows the result. From the
SCM value of P 0 156 of cultured
lymphocytes, LNE increased the SCM to
P = 0 291 (186o% of control) but the GCE
was without effect (P 0-153 or 98% of
control).
TABLE IV. SC-1of Cultured Human
Peripheral Lymphocytes
Polarization P %
Treatment value P control
Cultured lymphocytes 0 156 100
add lymph node extract
30,000-50,000 daltons
fraction
a(ld granulocyte extract
500-1000 daltons fraction
0-291
0* 15'3
The SCM of cells is measulredI by the fluorescence
polarization value, P.
DISCUSSION
Progression of cells from the resting
phase (Go or G1) into the cell cycle is
accompanied by a decrease in SCM. This
biophysical change affects the rate con-
stants of enzyme reactions in the cell and
it is therefore to be expected that changes
in SCM could be important in the regula-
tion of proliferative processes (Cercek and
Cercek, 1973a; Cercek, Cercek and Ockey,
] 973c).
Triggering of normal human lympho-
cytes into cell cycle by mitogens such as
phytohaemagglutinin, results in an im-
mediate and with time progressive decrease
in SCM (Cercek, Cercek and Garrett,
1973d). By analogy, we make the hypo-
thesis that the biological effects of growth
inhibitors such as " chalones " will be
accompanied by an increase in SCM,
inducing a biophysical state which is
characteristic for the cells in, or approach-
ing, the resting phase of the cells.
To ascertain that the observed increase
in the degree of fluorescence polarization,
P, are indeed the result of changes in SCM
due to the biological effects of inhibitors
and not a physicochemical phenomenon of
selective quenching of the fluorescein
fluorescence by the extracts, the yields of
fluorescein fluorescence in the presence and
absence of extracts have been measured.
The extracts used in our experiments had
no effect on the quantum yield, indicating
that the increases in values ofP are caused
by changes in SCM.
With regard to the experimental
results, Table V is a composite ofTables I-
TII and shows the percentage change in
SCM in each of the tests. The extracts
considered to be active in inhibitory
function are shown in heavy type. For
LNE, this is 30,000-50,000 daltons (La-
salvia et al., 1970; Houck et al., 1971).
For both GCE and RCE it is reported as
< 5000 daltons, probably 2000-4000
daltons (Rytomaa and Kiviniemi, 1968;
Paukovits, 1971; Kivilaasko and Rytomaa,
1971). However, Dr D. J. Pillinger of
these laboratories suggested, on the basis
ofSephadex column fractionation, that the
real activity may in fact reside somewhere
below 1000 daltons (personal communica-
tion). Accordingly, both the 500-1000
and 1000-10,000 dalton fractions are
shown in heavy type as possible inhibitory
regions. It is clear from this Table that
there is a highly significant correlation
between the " active " extracts and the
cell types which are affected. A complete
picture of specificity of blood cell extracts
for cells oftheir own type is demonstrated.
The exception to correlating the effect
completely with the supposedly " active "
fractions is the large (30,000-50,000
daltons) red cell extract which is as
effective as the 2 smaller ones. This may
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TABLE V. Percentage Change in SCM of Haemopoietic Cells when Treated with Mature
Blood Cell Extracts
Cell type tested
,~~~~~ _
Extract
Lymph node extract (LNE)
Granulocyte extract, (GCE)
Erythrocyte extract (RCE)
Molecular
weight
range
500-1000
1000-10000
30000-50000
500-1000
1000-10000
:30000-50000
500-1000
1000-10000
30000-50000
Cultured
Normal granulocytic
lymphocytes cells
+2
+7
+44
+1
+1
0
-1
-1I
-1I
+4
-2
+2
+42
+13
+4
-2
-2
-4
Molecular weight ranges shown in heavy type are the ranges containing active inhibitory material
according to the reported data (see text). Highly significant changes in the SCM of the test cells are also
shown in heavy type.
be due to a feature of the fractionation
technique. Each fraction is necessarily
contaminated to a small degree by the
lower molecular weight fractions since the
method depends simply on differential
molecular concentration. In each ultra-
filtration procedure a small volume of
concentrate is retained which has not
passed through the filter. The degree of
contamination depends on the initial
volume of crude extract. In the case of
red cell extracts this was low so that con-
tamination of the 30,000-50,000 dalton
fraction with the smaller molecular sizes
was relatively high. However, none of
the LNE nor GCE fractions have any
effect on the foetal liver cells so that the
specificity ofRCE for normoblasts remains
beyond question. The same argument
may be applied to the GCE. Contamina-
tion here is smaller because the initial
volume of crude extract is higher. The
relatively small effect of the 1000-10,000
dalton fraction may simply be due to
such a contamination therefore, and add
weight to Dr Pillinger's suggestion that
inhibitory activity is likely to reside in the
< 1000 dalton molecular weight range.
In these comparisons the lymphoid test
cells are probably not, strictly speaking,
proliferating. PHA initiates the pro-
cesses leading to a cell cycle but whether
the cells are by this stage, i.e. 15-30 min
after application of PHA to the lympho-
cytes in the G1 phase of a cell cycle is
doubtful. The effect of the large LNE
fraction on these cells is, however, clearcut
but the question arises whether in this case
it can be related to proliferation inhibition.
By allowing the PHA-lymphocyte culture
to proceed for 48 hours before testing, the
lymphocytes certainly are in cell cycle and,
as Table IV shows, LNE produced a
profound effect on the SCM of these cells
whereas the granulocyte active GCE
fraction remained ineffective. Further
studies in these laboratories have shown
that LNE inhibits the incorporation of
tritiated thymidine by PHA stimulated
lymphocytes irrespective of when it is
applied throughout the whole 72 hours
period of a PHA culture (Shah and Lord,
unpublished observations).
Clearly the problem associated with
possible thymidine contamination of the
extract affecting the incorporation of
labelled thymidine does not enter into this
sort of measurement. However, it is pos-
sible that thymidine may affect the pro-
liferation of the cells directly. Accord-
ingly, measurements of SCM of PHA
stimulated lymphocytes were made after
treatment with thymidine solutions.
Solutions of thymidine at 0 3 ,ug/ml (equi-
valent to contamination ofthe extract
with thymidine) and at 3 3 ,ug/ml (equi-
Test extract
_ A
Foetal liver
normoblasts
+2
t 5
+2
-3
+4
+4
+51
+48
+46
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TABLE VI.-Effect of Thymidine on SCM
of Normal Human Peripheral Lympho-
cytes
Polarization P /
Treatment value P control
Normal lymphocytes (NL) 0* 196 100
NL+PHA 0-145 74
0 3 jug thymidine per ml 0 150 76-5
(NL+PHA)
3-3 ,ug thymidine per ml 04138 70 5
(NL+PPHA)
The SCM of cells is measured by the fluorescence
polarization value, P.
valent to 10% contamination) were incu-
bated for 30 min with the stimulated
lymphocytes. Table VI showsthe results.
It is clear that these high concentrations of
thymidine (> 10-2 mmol/l comparedwith,
for example, < 10-3 mmol/l concentration
ofactive LNE) have no direct effect on the
SCM of lymphocytes. It is, however,
barely conceivable that the degree of
specificity demonstrated by the results
shown in this paper could be accounted for
by the thymidine contamination.
The questions of dose of extract, the
timing ofthe application ofthe extract and
the nature of the effect are still to be
elucidated, but from these preliminary
observations it is clear that extracts from
the mature cellular elements of haemo-
poietic tissues are capable ofproducing an
effect which is specific for the precursor
cells of their own kind only. While the
measurement made, that of changes of
SCM, may be due to changes other than in
the proliferative state of the cells, it is
clear that changes in the cell's proliferative
state do produce definitive changes of
SCM. It is probable, therefore, that the
extracts may be having a " chalone-like "
effect, i.e. that of inhibiting proliferation
of the cells.
It is also worth noting that the
lymphoid extracts were of bovine origin;
the granulocyte and erythrocyte extracts
were from rats. By contrast, the test
lymphoid cells were human and the
granulocytic and erythroid cells were from
mice. Thus, all these tests were success-
ful across the species barrier, which is
another of the criteria quoted for the
"chalone " type compounds.
This work was supported by grants
from the Cancer Research Campaign and
the Medical Research Council.
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